BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
71 – 80 of 3086
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment : Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry
(2019) In European Urology Focus
- Contribution to journal › Article
-
Mark
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer
- Contribution to journal › Article
-
Mark
Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy
Böös, Malin LU ; Jerlström, Tomas ; Beckman, Eva ; Bläckberg, Mats LU ; Brändstedt, Johan LU ; Kollberg, Petter LU ; Löfgren, Annica LU
; Malmström, Per Uno
; Sahlén, Göran
and Sörenby, Anne
LU
, et al.
(2019)
In Scandinavian Journal of Urology
53(5).
p.339-343
- Contribution to journal › Article
-
Mark
Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
Vallon-Christersson, Johan LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
; Saal, Lao
LU
; Larsson, Christer
LU
; Ehinger, Anna
LU
; Lindman, H
; Olofsson, Helena
; Sjoblom, Tobias
and Wärnberg, Fredrik
, et al.
(2019)
In Scientific Reports
9.
- Contribution to journal › Article
-
Mark
Diagnostic value of alternative techniques to gadolinium-based contrast agents in MR neuroimaging-a comprehensive overview
Falk Delgado, Anna ; Van Westen, Danielle LU
; Nilsson, Markus
LU
; Knutsson, Linda
LU
; Sundgren, Pia C
LU
; Larsson, Elna-Marie
LU
and Falk Delgado, Alberto
(2019)
In Insights into Imaging
10(1).
- Contribution to journal › Scientific review
-
Mark
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes
- Contribution to journal › Article
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
Mohlin, Sofie LU
; Hansson, Karin
LU
; Radke, Katarzyna
LU
; Martinez, Sonia
; Blanco-Apiricio, Carmen
; Garcia-Ruiz, Cristian
LU
; Welinder, Charlotte
LU
; Esfandyari, Javanshir
LU
; O'Neill, Michael
and Pastor, Joaquin
, et al.
(2019)
In EMBO Molecular Medicine
11(8).
- Contribution to journal › Article
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
Dihge, Looket LU ; Vallon-Christersson, Johan LU
; Hegardt, Cecilia
LU
; Saal, Lao
LU
; Häkkinen, Jari
LU
; Larsson, Christer
LU
; Ehinger, Anna
LU
; Loman, Niklas
LU
; Malmberg, Martin
LU
and Bendahl, Pär-Ola
LU
, et al.
(2019)
In Clinical Cancer Research
25(21).
p.6368-6381
- Contribution to journal › Article
-
Mark
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
Lundgren, Christine LU ; Bendahl, Pär-Ola LU ; Ehinger, Anna LU
; Hegardt, Cecilia
LU
; Larsson, Christer
LU
; Loman, Niklas
LU
; Malmberg, Martin
LU
; Olofsson, Helena
; Saal, Lao
LU
and Sjoblom, Tobias
, et al.
(2019)
In Breast Cancer Research and Treatment
p.1-9
- Contribution to journal › Article
-
Mark
Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide
Albertsson-Lindblad, Alexandra LU ; Freiburghaus, Catja LU ; Jerkeman, Mats LU and Ek, Sara LU
(2019)
In Experimental Hematology and Oncology
8(1).
- Contribution to journal › Article